about
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort studyEstimating transfer of bovine virus-diarrhoea virus in Danish cattle by use of register data.Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studySex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up.Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomesComparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studyEffectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial.β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.Dietary intake and adipose tissue content of long-chain n-3 PUFAs and subsequent 5-y change in body weight and waist circumference.A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study.Visual appearance and CMT score of foremilk of individual quarters in relation to cell count of cows milked automatically.Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity-Weighted Cohort Study.Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study.The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis.The HAS-BLED, ATRIA and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.Effects of hunger level and tube diameter on the feeding behavior of teat-fed dairy calves.Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study.Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study.Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study.Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study.Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke.Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism.Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study.Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.Effectiveness of self-managed oral anticoagulant therapy in patients with recurrent venous thromboembolism. A propensity-matched cohort study.Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillationDisease progression after ablation for atrial flutter compared with atrial fibrillation: A nationwide cohort studyTechnical note: Quantifying and characterizing behavior in dairy calves using the IceTag automatic recording deviceEffects of varying content of soluble dietary fibre from wheat flour and oat milling fractions on gastric emptying in pigsGenetic models for the inheritance of the silver colour mutation of foxesThe impact of diets varying in carbohydrates resistant to endogenous enzymes and lignin on populations of Ascaris suum and Oesophagostomum dentatum in pigsIndirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillationDabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort studyEdoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis
P50
Q29394400-7A63B0DA-D1DB-42C5-BA03-C7846F87A12DQ30664374-CF17B15B-4F0F-4E08-82E0-60413CC2015FQ33647367-8B3B1F50-49E9-4BBC-811F-70774D9D4E34Q34557287-BF655E47-9075-4DD0-AED9-9092E30545FAQ35494098-3454568F-45A7-4E40-AA41-0060013433F3Q37012525-5F5F2DC4-D97D-402C-A126-782564E64477Q38725712-27A678CD-324B-4876-ACFC-15AF70C96DECQ38813547-81EDC3A4-DF8A-44B2-9B97-37A3BE9A3F9EQ39324482-682D9B81-5591-458D-A1B8-6FB367A7A8AAQ40045311-76200C19-7411-4B83-B704-1721F9DAE25DQ40268104-5A308B87-DB33-4E6F-8AEF-7AE08C74A9DEQ40287579-8DFE45B8-A800-4122-B492-F3207EB9C88DQ40316771-973821B4-0018-4122-95E5-197844BB7B84Q40318282-83770155-1C10-4D54-A406-F6D8AD7252D1Q46030150-625AAB38-08DE-4128-9EC2-52F537428318Q47114683-B8D56D98-837A-4126-ACFB-D91B385855A4Q47139884-4FC268E3-E72C-4312-953C-E4EC83C5799DQ47155761-0DE28227-E0D1-4D1D-8947-416767D64EFEQ47254143-0497D0A0-99C3-454C-91F7-0D957DA19C30Q48215891-DCF51CA8-2F59-4CAC-A3D1-F79CD8AC0A01Q49565170-23ECC604-AAD9-4175-8D8B-FD8A68BE1748Q49832348-AED80B35-F43A-4225-AD32-CCD213CEFD5BQ50559863-AB2F9A78-00E1-474F-9843-82C2F4269726Q50562065-1D80D455-5A89-48A3-AD59-2942C2079FB5Q51150720-090EF67E-3BAF-4504-8BB7-EEDB5AD82F1FQ52140622-56061051-366B-4692-8F94-E948EE51B9CDQ52687408-3D3497C5-0C98-48BD-B3D4-126425390F28Q53355816-E1440710-8B2A-4B02-BA4A-415D2B6ED341Q53636515-6468315F-773C-4D38-AB0A-ED13B65B732CQ53694874-3C5DB089-D332-425C-AE1A-980C68C7DBAEQ54178643-810CDA35-1841-4EA5-85C8-8EA4DC2E88C3Q58562887-02276D55-A8D6-46DC-A6AA-7223A525D523Q60393479-460A621B-7C16-495D-9033-9629EE26524BQ61759199-D076F1AC-B519-4C44-806C-8826EA8A6FDBQ71480341-82D21076-E482-4EFE-B6B4-34D997B981ABQ72800972-8A7CCAEF-4ED3-4D44-A2AE-E1EDA58F5A33Q73389638-EF45414B-4D66-409B-8239-6045CF01AF11Q84561728-D2637F66-5CC9-4552-AFD6-E29F8F1E786BQ85259148-A87094BB-CD05-418D-AB6A-078A21B3AB9CQ85350306-EF1D8CBE-0ACA-4F6E-9D03-52B816498086
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Flemming Skjøth
@ast
Flemming Skjøth
@en
Flemming Skjøth
@es
Flemming Skjøth
@nl
Flemming Skjøth
@sl
type
label
Flemming Skjøth
@ast
Flemming Skjøth
@en
Flemming Skjøth
@es
Flemming Skjøth
@nl
Flemming Skjøth
@sl
prefLabel
Flemming Skjøth
@ast
Flemming Skjøth
@en
Flemming Skjøth
@es
Flemming Skjøth
@nl
Flemming Skjøth
@sl
P106
P31
P496
0000-0003-2975-647X